Katherine S. Zanotti - Jul 26, 2022 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
Director
Signature
/s/ Katherine S. Zanotti by Mark R. Busch, attorney-in-fact
Stock symbol
EXAS
Transactions as of
Jul 26, 2022
Transactions value $
-$161,096
Form type
4
Date filed
7/28/2022, 04:04 PM
Previous filing
Jul 1, 2022
Next filing
Jun 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Options Exercise $46.9K +4.61K +7.64% $10.18* 64.9K Jul 26, 2022 Direct F1, F2
transaction EXAS Common Stock Sale -$208K -4.61K -7.1% $45.14 60.3K Jul 26, 2022 Direct F3
holding EXAS Common Stock 3.74K Jul 26, 2022 By grantor retained annuity trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Stock Option (right to buy) Options Exercise $0 -4.61K -100% $0.00* 0 Jul 26, 2022 Common Stock 4.61K $10.18 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon exercise of a stock option award.
F2 The exercise reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into in November 2021.
F3 The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into in November 2021.